NCT00857883View on ClinicalTrials.gov

A First-Time-In-Human Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

November 17, 2008

Primary Completion Date

August 1, 2009

Study Completion Date

August 1, 2009

Conditions

Obesity

Interventions

DRUG

GSK1521498 or placebo

GSK1521498 is a mu-opioid receptor inverse agonist

Trial Locations (1)

CB2 0QQ

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY